842 related articles for article (PubMed ID: 17030271)
41. Optimal extent of lymph node dissection for Siewert type II esophagogastric junction carcinoma.
Yamashita H; Katai H; Morita S; Saka M; Taniguchi H; Fukagawa T
Ann Surg; 2011 Aug; 254(2):274-80. PubMed ID: 21772128
[TBL] [Abstract][Full Text] [Related]
42. Esophagogastric junction adenocarcinoma according to Siewert classification in Taiwan.
Fang WL; Wu CW; Chen JH; Lo SS; Hsieh MC; Shen KH; Hsu WH; Li AF; Lui WY
Ann Surg Oncol; 2009 Dec; 16(12):3237-44. PubMed ID: 19636628
[TBL] [Abstract][Full Text] [Related]
43. Diagnosis and treatment of non-metastatic esophagogastric junction adenocarcinoma: what are the current options?
Gronnier C; Piessen G; Mariette C
J Visc Surg; 2012 Feb; 149(1):e23-33. PubMed ID: 22341763
[TBL] [Abstract][Full Text] [Related]
44. Clinicopathological features and prognostic factors of adenocarcinoma of the esophagogastric junction according to Siewert classification: experiences at a single institution in Japan.
Hosokawa Y; Kinoshita T; Konishi M; Takahashi S; Gotohda N; Kato Y; Daiko H; Nishimura M; Katsumata K; Sugiyama Y; Kinoshita T
Ann Surg Oncol; 2012 Feb; 19(2):677-83. PubMed ID: 21822549
[TBL] [Abstract][Full Text] [Related]
45. Mediastinal lymph node dissection and distal esophagectomy is not essential in early esophagogastric junction adenocarcinoma.
Lee IS; Ahn JY; Yook JH; Kim BS
World J Surg Oncol; 2017 Jan; 15(1):28. PubMed ID: 28100248
[TBL] [Abstract][Full Text] [Related]
46. [Optimal surgical approach for esophagogastric junction carcinoma].
Yamashita H; Seto Y
Nihon Geka Gakkai Zasshi; 2015 Jan; 116(1):40-4. PubMed ID: 25842812
[TBL] [Abstract][Full Text] [Related]
47. Thoracic lymph node involvement in adenocarcinoma of the esophagogastric junction and lower esophageal squamous cell carcinoma relative to the location of the proximal end of the tumor.
Mine S; Sano T; Hiki N; Yamada K; Kosuga T; Nunobe S; Shigaki H; Yamaguchi T
Ann Surg Oncol; 2014 May; 21(5):1596-601. PubMed ID: 24531703
[TBL] [Abstract][Full Text] [Related]
48. Staging and outcome depending on surgical treatment in adenocarcinomas of the oesophagogastric junction.
Reeh M; Mina S; Bockhorn M; Kutup A; Nentwich MF; Marx A; Sauter G; Rösch T; Izbicki JR; Bogoevski D
Br J Surg; 2012 Oct; 99(10):1406-14. PubMed ID: 22961520
[TBL] [Abstract][Full Text] [Related]
49. [Surgical treatment of Barrett carcinoma].
Fuchs KH
Zentralbl Chir; 2000; 125(5):443-9. PubMed ID: 10929629
[TBL] [Abstract][Full Text] [Related]
50. [Carcinoma of the gastroesophageal junction. General principles of surgical therapy].
Triggiani E; Liguori G; Sammarco G; Aloi V; Cavalcanti BS; Cristofaro MG; Triggiani S; Vescio G
Minerva Chir; 1990 Apr; 45(8):561-4. PubMed ID: 2388725
[TBL] [Abstract][Full Text] [Related]
51. Clinical characteristics, biologic behavior, and survival after esophagectomy are similar for adenocarcinoma of the gastroesophageal junction and the distal esophagus.
Leers JM; DeMeester SR; Chan N; Ayazi S; Oezcelik A; Abate E; Banki F; Lipham JC; Hagen JA; DeMeester TR
J Thorac Cardiovasc Surg; 2009 Sep; 138(3):594-602; discussion 601-2. PubMed ID: 19698841
[TBL] [Abstract][Full Text] [Related]
52. Surgical factors influence the outcome after Ivor-Lewis esophagectomy with intrathoracic anastomosis for adenocarcinoma of the esophagogastric junction: a consecutive series of 240 patients at an experienced center.
Ott K; Bader FG; Lordick F; Feith M; Bartels H; Siewert JR
Ann Surg Oncol; 2009 Apr; 16(4):1017-25. PubMed ID: 19189186
[TBL] [Abstract][Full Text] [Related]
53. Prevalence and topography of lymph node metastases in early esophageal and gastric cancer.
Gertler R; Stein HJ; Schuster T; Rondak IC; Höfler H; Feith M
Ann Surg; 2014 Jan; 259(1):96-101. PubMed ID: 24096772
[TBL] [Abstract][Full Text] [Related]
54. Risk stratification for early esophageal adenocarcinoma: analysis of lymphatic spread and prognostic factors.
Barbour AP; Jones M; Brown I; Gotley DC; Martin I; Thomas J; Clouston A; Smithers BM
Ann Surg Oncol; 2010 Sep; 17(9):2494-502. PubMed ID: 20349213
[TBL] [Abstract][Full Text] [Related]
55. [Modern diagnostics and stage-oriented surgery: therapy of adenocarcinoma of the esophagogastric junction].
Hölscher AH; Fetzner UK
Chirurg; 2012 Aug; 83(8):702-8, 710-1. PubMed ID: 22878576
[TBL] [Abstract][Full Text] [Related]
56. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the mid/distal esophagus: five-year survival of a randomized clinical trial.
Omloo JM; Lagarde SM; Hulscher JB; Reitsma JB; Fockens P; van Dekken H; Ten Kate FJ; Obertop H; Tilanus HW; van Lanschot JJ
Ann Surg; 2007 Dec; 246(6):992-1000; discussion 1000-1. PubMed ID: 18043101
[TBL] [Abstract][Full Text] [Related]
57. Extended surgery for cancer of the esophagus and gastroesophageal junction.
Lerut T; Coosemans W; Decker G; De Leyn P; Moons J; Nafteux P; Van Raemdonck D
J Surg Res; 2004 Mar; 117(1):58-63. PubMed ID: 15013715
[TBL] [Abstract][Full Text] [Related]
58. Treatment results of adenocarcinoma of the gastroesophageal junction.
Yonemura Y; Kojima N; Kawamura T; Tsukiyama G; Bandou E; Sakamoto N; Tsubosa Y; Sato H
Hepatogastroenterology; 2008; 55(82-83):475-81. PubMed ID: 18613391
[TBL] [Abstract][Full Text] [Related]
59. Clinical impact of endoscopic submucosal dissection for superficial adenocarcinoma located at the esophagogastric junction.
Yoshinaga S; Gotoda T; Kusano C; Oda I; Nakamura K; Takayanagi R
Gastrointest Endosc; 2008 Feb; 67(2):202-9. PubMed ID: 18226681
[TBL] [Abstract][Full Text] [Related]
60. Long-Term Survival in Patients with Gastroesophageal Junction Cancer Treated with Preoperative Therapy: Do Thoracic and Abdominal Approaches Differ?
Kneuertz PJ; Hofstetter WL; Chiang YJ; Das P; Blum M; Elimova E; Mansfield P; Ajani J; Badgwell B
Ann Surg Oncol; 2016 Feb; 23(2):626-32. PubMed ID: 26564243
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
